IRLAB Therapeutics has announced top-line results from the Phase IIb REACT-PD study evaluating its s...
Tura Group redovisade ett bra avslut på 2024. Omsättningsmässigt redovisades totala intäkter om 236 ...
Guiding for higher organic growth and margin expansion in 2025e Acquisition of Sounding Board should...
Redeye notes that Systemair continues to show healthy top-line growth in its third quarter of 2024/2...
Redeye shares a brief comment on Nitro Games’ new game project for an iGaming platform.
Gabather AB (“Gabather” or “the Company”) is advancing GT-002, a first-in-class GABAA-modulator, thr...
Redeye comments on the disappointing news that IRLAB’s drug candidate Pirepemat did not meet its pri...
Suominen's Q4 comparable EBITDA fell clearly short of Vara Research consensus, owing to volume press...
42% decrease of fall rate with pirepemat... ...but no stat.
Substansvärdet sjönk till 4,41 kr vid utgången av 2024 och Fastator avslutade framgångsrikt de skrif...
Eurobio will cover France, Benelux, Germany, Switzerland, and the UK.
Analysguiden inleder bevakning av gruvbolaget Grangex.
Suominen Q4 comparable EBITDA of EUR 4.2m fell 40% short of Vara Research consensus expectation of E...
2024 saw 48% EBITA growth and 86% cash conversion We raise '25e-'26e EBITA by 19-15%, mainly on Dovr...
Djupgående diskussioner med intressenter Sedan det positiva studieresultatet offentliggjordes i nove...
